Citigroup »

Aurinia Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 1.4M 8.99
2023-09-30 $7.5M 964k 7.75
2023-03-31 $9.3M 849k 10.96
2022-12-31 $3.7M 850k 4.32
2022-09-30 $6.4M 851k 7.52
2021-12-31 $18M 768k 22.87
2021-03-31 $32k 2.4k 13.14
2020-12-31 $53k 3.8k 13.91
2020-09-30 $154k 11k 14.68
2020-06-30 $328k 20k 16.18
2020-03-31 $95k 6.6k 14.42
2019-12-31 $257k 13k 20.27
2019-09-30 $23k 4.2k 5.38
2019-06-30 $14k 2.1k 6.56
2019-03-31 $8.0k 1.3k 6.38
2018-12-31 $0 55 0.00
2018-09-30 $0 52 0.00
2018-06-30 $17k 3.0k 5.67
2018-03-31 $18k 3.4k 5.46
2017-12-31 $23k 4.8k 4.74
2017-09-30 $19k 3.0k 6.33
2017-06-30 $18k 3.0k 6.00
2017-03-31 $132k 18k 7.33
2015-12-31 $0 6 0.00